enkephalin, leucine and Basal Ganglia Diseases

enkephalin, leucine has been researched along with Basal Ganglia Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azdad, K; Ciruela, F; Cunha, R; Ferré, S; Franco, R; Lluis, C; Popoli, P; Quiroz, C; Schiffmann, SN; Woods, AS	1
Egan, MF; Hurd, Y; Hyde, TM; Kleinman, JE; Weinberger, DR; Wyatt, RJ	1
Ableitner, A	1
Chesselet, MF; Mercugliano, M	1
Tan, MX	1

Reviews

2 review(s) available for enkephalin, leucine and Basal Ganglia Diseases

Article	Year
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Current pharmaceutical design, 2008, Volume: 14, Issue:15 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenylyl Cyclases; Animals; Basal Ganglia; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Enkephalins; Enzyme Activation; gamma-Aminobutyric Acid; GTP-Binding Proteins; Humans; Neurons; Phosphorylation; Receptor, Adenosine A2A; Receptors, Dopamine D2; Substance-Related Disorders	2008
[Peptide neurotransmitters and extrapyramidal disorders]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4 Topics: Animals; Basal Ganglia Diseases; Enkephalins; Humans; Huntington Disease; MSH Release-Inhibiting Hormone; Parkinson Disease; Substance P	1985

Article

Year

An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

Current pharmaceutical design, 2008, Volume: 14, Issue:15

Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenylyl Cyclases; Animals; Basal Ganglia; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Enkephalins; Enzyme Activation; gamma-Aminobutyric Acid; GTP-Binding Proteins; Humans; Neurons; Phosphorylation; Receptor, Adenosine A2A; Receptors, Dopamine D2; Substance-Related Disorders

2008

[Peptide neurotransmitters and extrapyramidal disorders].

Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4

Topics: Animals; Basal Ganglia Diseases; Enkephalins; Humans; Huntington Disease; MSH Release-Inhibiting Hormone; Parkinson Disease; Substance P

1985

Other Studies

3 other study(ies) available for enkephalin, leucine and Basal Ganglia Diseases

Article	Year
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse (New York, N.Y.), 1994, Volume: 18, Issue:3 Topics: Animals; Basal Ganglia Diseases; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P	1994
Brain sites involved in delta-opioid receptor-mediated actions. European journal of pharmacology, 1994, Dec-12, Volume: 271, Issue:1 Topics: Amino Acid Sequence; Animals; Autoradiography; Basal Ganglia Diseases; Brain; Brain Mapping; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Glucose; Injections, Intraventricular; Male; Molecular Sequence Data; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta	1994
Clozapine decreases enkephalin mRNA in rat striatum. Neuroscience letters, 1992, Feb-17, Volume: 136, Issue:1 Topics: Animals; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Depression, Chemical; Efferent Pathways; Enkephalins; Gene Expression Regulation; Globus Pallidus; Haloperidol; Male; Nucleic Acid Hybridization; Protein Precursors; Rats; Rats, Inbred Strains	1992